Logo image of BOW

BOWHEAD SPECIALTY HOLDINGS I (BOW) Stock Fundamental Analysis

NYSE:BOW - New York Stock Exchange, Inc. - US10240L1026 - Common Stock - Currency: USD

41.17  -0.25 (-0.6%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BOW. BOW was compared to 143 industry peers in the Insurance industry. While BOW seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, BOW is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

BOW had positive earnings in the past year.
BOW had a positive operating cash flow in the past year.
BOW Yearly Net Income VS EBIT VS OCF VS FCFBOW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

BOW has a Return On Assets (2.31%) which is in line with its industry peers.
The Return On Equity of BOW (10.32%) is comparable to the rest of the industry.
BOW's Return On Invested Capital of 4.16% is fine compared to the rest of the industry. BOW outperforms 72.73% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BOW is in line with the industry average of 4.42%.
The last Return On Invested Capital (4.16%) for BOW is above the 3 year average (4.13%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.31%
ROE 10.32%
ROIC 4.16%
ROA(3y)2.25%
ROA(5y)N/A
ROE(3y)12.29%
ROE(5y)N/A
ROIC(3y)4.13%
ROIC(5y)N/A
BOW Yearly ROA, ROE, ROICBOW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2 4 6 8 10

1.3 Margins

BOW has a Profit Margin of 8.98%. This is comparable to the rest of the industry: BOW outperforms 56.64% of its industry peers.
BOW has a Operating Margin of 20.78%. This is in the better half of the industry: BOW outperforms 78.32% of its industry peers.
Industry RankSector Rank
OM 20.78%
PM (TTM) 8.98%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BOW Yearly Profit, Operating, Gross MarginsBOW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 5 10 15 20

More info and screens

4

2. Health

2.1 Basic Checks

BOW has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BOW has more shares outstanding
There is no outstanding debt for BOW. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BOW Yearly Shares OutstandingBOW Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
BOW Yearly Total Debt VS Total AssetsBOW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

There is no outstanding debt for BOW. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC0.46
WACC8.97%
BOW Yearly LT Debt VS Equity VS FCFBOW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 100M 200M 300M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BOW Yearly Current Assets VS Current LiabilitesBOW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 62.21% over the past year.
Looking at the last year, BOW shows a very strong growth in Revenue. The Revenue has grown by 50.20%.
EPS 1Y (TTM)62.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-49.11%
Revenue 1Y (TTM)50.2%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-62.29%

3.2 Future

BOW is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.29% yearly.
Based on estimates for the next years, BOW will show a very strong growth in Revenue. The Revenue will grow by 23.64% on average per year.
EPS Next Y21.16%
EPS Next 2Y21.94%
EPS Next 3Y20.29%
EPS Next 5YN/A
Revenue Next Year35.47%
Revenue Next 2Y28%
Revenue Next 3Y23.64%
Revenue Next 5YN/A

3.3 Evolution

BOW Yearly Revenue VS EstimatesBOW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 200M 400M 600M
BOW Yearly EPS VS EstimatesBOW Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 34.60, which means the current valuation is very expensive for BOW.
79.02% of the companies in the same industry are cheaper than BOW, based on the Price/Earnings ratio.
BOW is valuated rather expensively when we compare the Price/Earnings ratio to 28.18, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 25.46, which means the current valuation is very expensive for BOW.
BOW's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. BOW is more expensive than 75.52% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.81. BOW is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 34.6
Fwd PE 25.46
BOW Price Earnings VS Forward Price EarningsBOW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BOW's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, BOW is valued a bit cheaper than 74.13% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.62
EV/EBITDA 13.6
BOW Per share dataBOW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BOW's earnings are expected to grow with 20.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.63
PEG (5Y)N/A
EPS Next 2Y21.94%
EPS Next 3Y20.29%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BOW!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BOWHEAD SPECIALTY HOLDINGS I

NYSE:BOW (5/5/2025, 10:54:02 AM)

41.17

-0.25 (-0.6%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-25 2025-02-25/bmo
Earnings (Next)05-06 2025-05-06/bmo
Inst Owners90.25%
Inst Owner Change2.08%
Ins Owners4.07%
Ins Owner Change2.91%
Market Cap1.34B
Analysts74
Price Target40.8 (-0.9%)
Short Float %2.29%
Short Ratio2.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.55%
Min EPS beat(2)2.89%
Max EPS beat(2)26.2%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.15%
Min Revenue beat(2)-4.62%
Max Revenue beat(2)4.32%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.53%
PT rev (3m)9.89%
EPS NQ rev (1m)-1.25%
EPS NQ rev (3m)-5.23%
EPS NY rev (1m)-1.28%
EPS NY rev (3m)-1.14%
Revenue NQ rev (1m)2.7%
Revenue NQ rev (3m)6.85%
Revenue NY rev (1m)0.86%
Revenue NY rev (3m)6.57%
Valuation
Industry RankSector Rank
PE 34.6
Fwd PE 25.46
P/S 3.16
P/FCF 4.62
P/OCF 4.57
P/B 3.63
P/tB 3.63
EV/EBITDA 13.6
EPS(TTM)1.19
EY2.89%
EPS(NY)1.62
Fwd EY3.93%
FCF(TTM)8.92
FCFY21.65%
OCF(TTM)9.01
OCFY21.89%
SpS13.03
BVpS11.34
TBVpS11.34
PEG (NY)1.63
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.31%
ROE 10.32%
ROCE 5.41%
ROIC 4.16%
ROICexc 4.42%
ROICexgc 6.1%
OM 20.78%
PM (TTM) 8.98%
GM N/A
FCFM 68.41%
ROA(3y)2.25%
ROA(5y)N/A
ROE(3y)12.29%
ROE(5y)N/A
ROIC(3y)4.13%
ROIC(5y)N/A
ROICexc(3y)4.58%
ROICexc(5y)N/A
ROICexgc(3y)6.42%
ROICexgc(5y)N/A
ROCE(3y)5.37%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 80.46%
Cap/Sales 0.73%
Interest Coverage 250
Cash Conversion 318.78%
Profit Quality 761.38%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC8.97%
ROIC/WACC0.46
Cap/Depr(3y)265.07%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.4%
Cap/Sales(5y)N/A
Profit Quality(3y)1089.24%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-49.11%
EPS Next Y21.16%
EPS Next 2Y21.94%
EPS Next 3Y20.29%
EPS Next 5YN/A
Revenue 1Y (TTM)50.2%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-62.29%
Revenue Next Year35.47%
Revenue Next 2Y28%
Revenue Next 3Y23.64%
Revenue Next 5YN/A
EBIT growth 1Y64.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y24.58%
OCF growth 3YN/A
OCF growth 5YN/A